Rick Matthews: A Milestone in DVT Treatment and Patient Access from Vein and Vascular Institute and NBCA
Rick Matthews, Senior Vascular Consultant at Argon Medical Devices, Inc., reposted from National Blood Clot Alliance on LinkedIn:
”As someone who has worked closely in vascular and clot management, I think this is a major milestone.
Many DVT patients present first in community settings, so building systems that support rapid diagnosis, thoughtful intervention, and long-term follow-up is incredibly important.
Congratulations to Vein and Vascular Institute and NBCA for helping raise the standard of care and expand access to high-quality DVT treatment.”
Quoting National Blood Clot Alliance‘s post:
”A major step forward in expanding access to high-quality blood clot care.
We’re proud to announce that Vein and Vascular Institute has been named the nation’s first National Blood Clot Alliance Community DVT Excellence Center — setting a new standard for patient-centered, evidence-based care in community settings.
Why this matters:
Patients with deep vein thrombosis (DVT) often first seek care outside of hospital systems.
Ensuring these settings are equipped to deliver timely diagnosis, coordinated treatment, and appropriate follow-up is critical to improving outcomes and preventing complications.
This designation reflects a strong commitment to:
- Rapid evaluation and diagnosis
- Evidence-based treatment
- Coordinated, patient-centered care
- Ongoing education and awareness
This milestone marks the expansion of NBCA’s national network of excellence — bringing high-quality blood clot care closer to where patients are.
Want to go deeper?
Join us tomorrow for our webinar: Building a VTE Center of Excellence: Standards, Strategy, and System-Wide Impact

Stay updated with Hemostasis Today.
-
Sep 29, 2026, 03:53Nahrwan Masaoodi: Iron Deficiency Can Exist Without Anemia
-
Sep 29, 2026, 03:38Muhammad Yousaf: Iron Deficiency Beyond Diet
-
Sep 29, 2026, 03:21Parvez Ahmed Chowdhury: Synthesizing Aspirin in the Organic Chemistry Lab
-
Sep 29, 2026, 03:12Ahmed Hamandi: Building the Future of Hematopoietic Transplantation in Iraq
-
Sep 29, 2026, 03:09M V Chandrakanth: Aspirin in CRC – Old Drug, New Precision Oncology?
-
Sep 29, 2026, 03:07Caroline Pothet: Advancing Treatment Development in Sickle Cell Disease and Thalassaemia
-
Sep 29, 2026, 02:53Astha Jain: Thalassemia Care Through a Public Health Lens
-
Sep 29, 2026, 02:50Emma Groarke: Starting a New Career Path in Homeland
-
Sep 28, 2026, 19:14Aditya Sharma: An Outstanding Start to the Final Day of VSS 2026!